RESMED INC — Director's Dealing 2023

Nov 21, 2023

SEC Form 4/A — Form 4/A

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-11-16

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-16	ResMed Common Stock	M	3462	$57.76	Acquired	444448	Direct
2023-11-16	ResMed Common Stock	F	1343	$148.90	Disposed	443105	Direct
2023-11-20	ResMed Common Stock	F	2352.929	$148.94	Disposed	440752	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-16	ResMed Common Stock Options	$57.76	M	3462	Disposed	2023-11-16	ResMed Common Stock (3462)	Direct
2023-11-16	ResMed Common Stock Options	$148.90	A	55468	Acquired	2030-11-16	ResMed Common Stock (55468)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	4090	Indirect

Footnotes

F1: Original form amended to include a plan provision auto-exercise prior to option grant expiration.

F2: Disposition to issuer for exercise cost of options auto-exercised under the plan.

F3: Disposition to issuer for tax withholding on vesting of Performance Restricted Stock Units granted on 11/19/2020.

F4: Transaction was a plan auto exercise prior to expiration.

F5: Represents date options first become exercisable. Options vest 1/3 annually each November 11, 2024, 2025, and 2026.